Phase I Trial to Investigate Cafusertib Hydrochloride in Combination With Low Dose Cytarabine in Chinese Patients With Acute Myeloid Leukaemia (AML)

NCT02140606 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

INDUSTRY

Sponsor class

Conditions

Leukemia, Myeloid, Acute

Interventions

DRUG: Cafusertib Hydrochloride

Sponsor

Jiangsu Hansoh Pharmaceutical Co., Ltd.